India Non-Invasive Prenatal Testing (NIPT) Market and Forecast 2022-2028

  • Product Code:
    RP-ID-10352368
  • Published Date:
    9 Jun 2022
  • Region:
    Country
  • Pages:
    65
  • Category:
    Healthcare & Pharmaceuticals
  • Publisher:
    Pub-ID-24

Impact Analysis on the Growth of Market

Inflation and Looming Recession to Haunt Businesses:

In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022.

..

..

The Research Report is Updated with 2021 Base Year, 2022 Estimated year and Forecast till 2031 with Market Insights.


With the dip in global production, the GDP has contracted in 2020 and impacted the market across the world. Upon placing a Sample Request, you will receive an updated report with 2021 as base year, 2022 as estimated year and forecast to 2031. This will have market drivers, recovery rate in the market, insights and competitive analysis.



Market Overview:

Translate Report

"Indian Non-Invasive Prenatal Testing (NIPT) Market size is expected to reach USD 62 million by 2028. The market is expected to expand at a CAGR of more than 11% from 2022 to 2028.

India's Non-Invasive Prenatal Testing Market is growing with the increasing per capita income, growing interest, increase in incidences of chromosomal aneuploidies among fetus, development of advanced non-invasive prenatal testing products, rising awareness regarding non-invasive prenatal testing. The market shows high potential for growth in the future.

This new market report presents a comprehensive study of the entire Indian non-invasive prenatal testing market. The report offers the most up–to–date industry data on the actual market situation and future outlook for the India non-invasive prenatal testing market. The report also provides up–to–date historical market size data for the period 2018 – 2021 and an illustrative forecast to 2028 covering key market aspects like market value and volume for non-invasive prenatal testing in India.

 

This Comprehensive India’s Non-Invasive Prenatal Testing Market Research Report Provides:

 

• To Analyse the Historical Growth in the Market Size of the India Non–Invasive Prenatal Testing Market from 2018 to 2021
• To Estimate and Forecast the Market Size of the India Non–Invasive Prenatal Testing Market from 2022 to 2028 and Growth Rate until 2028
• Evaluates the Number of NIPT Tests Performed in India with Six Years Forecast
• Assessment of Market Potential and Opportunities for this Innovation-Driven India Non–Invasive Prenatal Testing Market with Six Years Forecast
• Meticulously Assesses the Overall United States Potential Non–Invasive Prenatal Testing (NIPT) Volume and Future Trends
• Detailed Insights into the Regulatory Framework of the India Non–Invasive Prenatal Testing Market 
• Features Reimbursement Patterns of the India Non–Invasive Prenatal Testing Market 
• Tracks Competitive Developments, Approaches, Recent Industry Developments, Mergers & Acquisitions, Collaboration Deals, Partnership Deals, Distribution, Exclusive, and Licensing Agreement
• A Comprehensive List of the Key Players Along with the Analysis of their Current NIPT Test Portfolios, Business Overview, and Recent Development.

 

The Leading Companies for the Indian Non–Invasive Prenatal Testing Market are Listed Below:

 

• Medgenome
• DNA Labs India
• LifeCell
• Apollo Centre for Fetal Medicine
• Igenomix India
• Fortis Healthcare Limited
• DNA Forensics Laboratory Pvt. Ltd.
• Thyrocare Technologies Limited

 

Key Questions Answered in this Report:

 

• What is the current scenario of the Indian non–invasive prenatal testing market?
• What is the total market size and forecast (until 2028) for the Indian non–invasive prenatal testing market?
• How has the potential Indian market performed so far and how will it perform in the coming years?
• How many NIPT tests were performed in India during 2018 – 2028?
• What are the key marketed NIPT tests available in India?
• What are the major drivers of the Indian non–invasive prenatal testing market?
• What are the major inhibitors of the Indian non–invasive prenatal testing market?
• What is the reimbursement pattern in the Indian non–invasive prenatal testing market?
• What is the regulatory framework in the Indian non–invasive prenatal testing market?
• What are the major deals and agreement happenings in the non–invasive prenatal testing market?
• Who are the top Indian market players? What are their happenings, current developments, and scenarios?
• How is the Indian market predicted to develop in the future?"



.

"1. Executive Summary

2. India Actual Non–Invasive Prenatal Testing Volume (Number of Tests Performed) and Forecast (2018 – 2028) 

3. India Potential Non–Invasive Prenatal Testing Volume (Number of Tests Performed) and Forecast (2018 – 2028)
 
4. India Actual Non–Invasive Prenatal Testing Market Size and Forecast (2018 – 2028) 

5. India Potential Non–Invasive Prenatal Testing Market Size and Forecast (2018 – 2028) 

6. India Non–Invasive Prenatal Testing Market Growth Drivers and Challenges

7. Non–Invasive Prenatal Testing Comparative Analysis

8. Reimbursement Environment of the India Non-Invasive Prenatal Testing Market

9. Regulation Framework of the India Non-Invasive Prenatal Testing Market

10. Major Deals and Agreements in the Non–Invasive Prenatal Testing Market
10.1 Collaboration Deals
10.2 Venture Capital Investment
10.3 Mergers and Acquisitions
10.4 Exclusive Agreement
10.5 Licensing Agreement
10.6 Distribution Agreement
10.7 Partnership Deals

11. Key Companies Analysis
11.1 Medgenome
11.1.1 Business Overview
11.1.2 Product Portfolio
11.1.3 Recent Development
11.2 DNA Labs India
11.2.1 Business Overview
11.2.2 Product Portfolio
11.2.3 Recent Development
11.3 LifeCell
11.3.1 Business Overview
11.3.2 Product Portfolio
11.3.3 Recent Development
11.4 Apollo Centre for Fetal Medicine
11.4.1 Business Overview
11.4.2 Product Portfolio
11.4.3 Recent Development
11.5 Igenomix India
11.5.1 Business Overview
11.5.2 Product Portfolio
11.5.3 Recent Development
11.6 Fortis Healthcare Limited
11.6.1 Business Overview
11.6.2 Product Portfolio
11.6.3 Recent Development
11.7 DNA Forensics Laboratory Pvt. Ltd
11.7.1 Business Overview
11.7.2 Product Portfolio
11.7.3 Recent Development
11.8 Thyrocare Technologies Limited
11.8.1 Business Overview
11.8.2 Product Portfolio
11.8.3 Recent Development"

Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report
Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

Related Reports

-->